---
figid: PMC2921766__nihms202026f8
figlink: /pmc/articles/PMC2921766/figure/F8/
number: Figure 8
caption: 'D2R/S100B Signaling Pathway: D2R agonist or BRC activate G-protein-coupled
  inhibitory receptor, D2R, causing Gi proteins to bind and inhibit adenylate cyclase
  cAMP production, lowering PKA activity and decreasing S776 phosphorylation of PKA
  substrate ataxin-1, reducing inclusion bodies and neurodegeneration. FSK or other
  adenylate cyclase activator increases cAMP production and PKA activity, increasing
  S776 phosphorylation of PKA substrate ataxin-1, producing inclusion bodies and increasing
  neurodegeneration. H89 inhibits PKA S776 phosphorylation of ataxin-1. BRC could
  be potentially therapeutic by reducing mutant ataxin-1 S776 phosphorylation and
  reducing SCA1 neurodegeneration.'
pmcid: PMC2921766
papertitle: Dopamine D2 Receptor Signaling Modulates Mutant Ataxin-1 S776 Phosphorylation
  and Aggregation.
reftext: SM Hearst, et al. J Neurochem. ;114(3):706-716.
pmc_ranked_result_index: '66501'
pathway_score: 0.9500099
filename: nihms202026f8.jpg
figtitle: Dopamine D2 Receptor Signaling Modulates Mutant Ataxin-1 S776 Phosphorylation
  and Aggregation.
year: ''
organisms: Homo sapiens
ndex: dbd88347-dee8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2921766__nihms202026f8.html
  '@type': Dataset
  description: 'D2R/S100B Signaling Pathway: D2R agonist or BRC activate G-protein-coupled
    inhibitory receptor, D2R, causing Gi proteins to bind and inhibit adenylate cyclase
    cAMP production, lowering PKA activity and decreasing S776 phosphorylation of
    PKA substrate ataxin-1, reducing inclusion bodies and neurodegeneration. FSK or
    other adenylate cyclase activator increases cAMP production and PKA activity,
    increasing S776 phosphorylation of PKA substrate ataxin-1, producing inclusion
    bodies and increasing neurodegeneration. H89 inhibits PKA S776 phosphorylation
    of ataxin-1. BRC could be potentially therapeutic by reducing mutant ataxin-1
    S776 phosphorylation and reducing SCA1 neurodegeneration.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNAT3
  - GNAI1
  - GNAZ
  - GNAT2
  - PRKAR2B
  - GNAO1
  - S100B
  - GNAI3
  - PRKAR1B
  - PRKAR2A
  - PRKACA
  - PRKAR1A
  - GNAT1
  - PRKACB
  - PRKACG
  - GNAI2
genes:
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: D2R/S100B
  symbol: S100B
  source: hgnc_symbol
  hgnc_symbol: S100B
  entrez: '6285'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
chemicals: []
diseases: []
---
